Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as detailed information on various hormonal compounds and pathological conditions. Notably, the revision number has been updated to v3.0.0.
    Difference
    4%
    Check dated 2025-08-30T12:13:16.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-16T04:48:48.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T00:14:59.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-01T19:32:58.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-25T15:13:46.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-18T12:05:39.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.